Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
AXSM
Axsome Therapeutics Completes Phase 3 Trials for AXS-05 in Alzheimer’s Agitation
| 2024-12-30 |
PHARMACEUTICAL
Axsome Therapeutics Initiates Phase 3 Trial for Binge Eating Disorder Treatment
| 2024-04-01 |
PHARMACEUTICAL
